Amyotrophic Lateral Sclerosis
FY22 Clinical Biomarker Development Award
The list of Fiscal Year 2022 Amyotrophic Lateral Sclerosis Research Program Clinical Biomarker Development Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
| Institution | Principal Investigator |
|---|---|
| Cold Spring Harbor Laboratory | Molly Gale Hammell |
| INmune Bio, Inc. | Kim Staats |
| Lawrence Livermore National Security, LLC | Michael Morrison |
| Louisiana State University Health Sciences Center | Shyamal Desai |
| Meso Scale Diagnostics, LLC | Martin Stengelin |
| NeuroDex, Inc. | Erez Eitan |
| St. Joseph's Hospital and Medical Center | Nadine Bakkar |
| University of California San Diego | Iris Broce-Diaz |
| University of Pennsylvania | Katheryn Cousins |
| University of Queensland | Michael O'Sullivan |
Last updated Thursday, December 1, 2022